Physician

Aaron E Katz, M.D.

According to 2025 Medicare claims, Aaron Katz, M.D. (NPI: 1740399922) practices urology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Nassau, NY. This provider's primary affiliated billing organization is NEW YORK UNIVERSITY (NPI: 1285826438; TIN: 472665045) and primary practice location at 11714-3927.

Katz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 878 traditional Medicare patients, billed 2,127 HCPCS/CPT codes, and received $348,640 in Medicare payments. The top billing code was 55874 (Injection of biodegradable material next to prostate). Part D data shows 1,373 prescription claims across 414 beneficiaries totaling $134,355 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 18 claims. Open Payments data shows 17 records totaling $2,527. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $678,296 to $348,640. Similarly, Part D prescription costs have declined steadily, from $355,564 to $134,355. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $743 to $250.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	905	10,691	$678,296
2016	987	13,771	$509,555
2017	1,014	25,993	$478,618
2018	1,014	21,022	$369,256
2019	1,044	13,898	$308,140
2020	860	9,555	$225,848
2021	1,009	3,820	$266,546
2022	879	4,025	$264,212
2023	869	3,175	$349,983
2024	878	2,127	$348,640

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	407	1,660	$355,564
2016	405	1,700	$416,589
2017	316	1,447	$393,967
2018	302	1,012	$433,070
2019	285	779	$120,498
2020	282	687	$52,258
2021	317	941	$229,203
2022	387	1,178	$111,152
2023	382	1,288	$105,531
2024	414	1,373	$134,355

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	41	$10,226
2016	N/R	33	$9,780
2017	N/R	61	$18,853
2018	N/R	34	$11,838
2019	N/R	N/R	N/R
2020	N/R	33	$17,408
2021	N/R	33	$10,294
2022	N/R	49	$19,083
2023	N/R	52	$25,604
2024	N/R	18	$14,870

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
55874	Injection of biodegradable material next to prostate	58	58	$2,668
52000	Diagnostic exam of bladder and urethra using an endoscope	51	54	$199
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	194	194	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	662	1,002	$100
36415	Insertion of needle into vein for collection of blood sample	264	339	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	26	960	$13,477
Silodosin	Silodosin	115	8,923	$13,211
Solifenacin Succinate	Solifenacin Succinate	99	6,180	$8,402
Tamsulosin Hcl	Tamsulosin Hcl	378	26,000	$5,032
Finasteride	Finasteride	328	24,041	$3,813

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	18	$14,870

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$2,527	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aaron E. Katz, M.D.?

Tedicare shows public-source Medicare data for Aaron E. Katz, M.D. (NPI 1740399922), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron E. Katz, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aaron E. Katz, M.D.?

Aaron E. Katz, M.D. is linked to NEW YORK UNIVERSITY (billing NPI 1285826438) in the available physician profile data.

Does Aaron E. Katz, M.D. have Open Payments data?

Aaron E. Katz, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.